Rahul Bajaj

Rahul Bajaj is a fourth year law student at the University of Nagpur. His interest in intellectual property law began taking a concrete shape when he pursued Professor William Fisher's online course on copyright law in the second year of law school. Since then, Rahul has worked on a diverse array of IP matters during his internships. He is particularly interested in studying the role of intellectual property law in facilitating access to education.

Others

SpicyIP Weekly Review (May 22-29)


SpicyIP Highlight of the Week Our highlight of the week undoubtedly has to be Prof. Basheer’s two-part analysis of the decision of Deputy Controller, Rajesh Dixit, overruling all the objections to the grant of a patent to Gilead for Sovaldi. In the first post, Prof. Basheer notes how the Deputy Controller erroneously conflated the ‘novelty’ and ‘inventive step’ enquiries while assessing Gilead’s application and came to the conclusion that the production of Sovaldi involved an inventive step by applying the…


Read More »
Drug Regulation Innovation Patent

Roche Moves Delhi HC to Challenge the Approval Granted by DCGI to Yet Another Biosimilar


A couple of weeks ago, I had analyzed the Delhi High Court’s judgment here and here, delivered by Justice Manmohan Singh, imposing some conditions on the sale of Roche’s breast cancer drug, Trastuzumab (Herceptin), by Biocon and Mylan. While Justice Singh allowed Biocon and Mylan to sell the biosimilar of Trastuzumab subject to some conditions, the decision was appealed to a Division Bench which has allowed the two companies to continue marketing the drug till 21st July. On the heels…


Read More »
Drug Regulation Innovation Patent

Grant of Patent to Gilead for Sovaldi Challenged in Delhi High Court


As our readers would recall, we had analyzed the Indian Patent Office’s decision to dismiss the multiple pre-grant opposition claims and consequently approve Gilead’s application for the grant of a patent for its hugely important Hepatitis C drug, Sovaldi, last week. The 58-page decision, which was issued by the Deputy Controller Rajesh Dixit, virtually amounted to a complete U-turn by the Patent Office which had rejected Gilead’s application for Sovaldi last January. The decision came in for sharp criticism, not…


Read More »
Data Exclusivity Drug Regulation Patent

Delhi HC Imposes Strict Conditions on the Sale of Biomedicines: Part 2/2


In part 1 of my analysis, I offered a brief summary of the Delhi High Court’s judgment imposing strict conditions on the sale of the biosimilar version of Roche’s breast cancer drug, Trastuzumab, by Biocon and Mylan. Before I delve into the findings of the single judge, I should point out that, as one of the commenters to my previous article noted, the decision has been stayed by a Division Bench and the matter is listed to be next heard…


Read More »
Data Exclusivity Drug Regulation Patent

Delhi HC Imposes Strict Conditions on the Sale of Biomedicines: Part 1/2


In an order that is likely to have wide-ranging ramifications on the biomedicine industry, the Delhi High Court on Monday (25th April) imposed some conditions on the sale of the biosimilar version of Roche’s breast cancer drug, Trastuzumab, by Biocon and Mylan. The decision, clocking in at 227 pages, discusses a number of profoundly important issues such as data exclusivity, patent linkage, norms to be followed for patient safety and the rights of patentees after the expiry of their patent….


Read More »
Copyright

Securing the Independence of the Copyright Board on Firmer Legal Moorings: Madras HC Takes a Step in the Right Direction


In a development that has sent constitutional law and IP nerds like yours truly into a tizzy, the Madras High Court has upheld the constitutionality of the Copyright Board (“the Board”) while striking down the composition of the committee responsible for selecting the members of the Board. As our readers would recall, we shared the details of the PIL filed by the South Indian Music Companies Association to challenge the constitutionality of the composition and method of functioning of the Board…


Read More »